Oramed Pharmaceuticals Inc.

SUSQUEHANNA INTERNATIONAL GROUP, LLP ORMP

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

25,984

Value ($000)

Weight

0.0%

2014 Q1 - 2025 Q4 (22 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	74	0.0%	25,984	12/31/2025
2025 Q3	11/14/2025	97	0.0%	36,825	9/30/2025
2025 Q2	8/14/2025	109	0.0%	48,428	6/30/2025
2025 Q1	5/14/2025	214	0.0%	100,196	3/31/2025
2024 Q4	2/14/2025	220	0.0%	91,027	12/31/2024
2024 Q3	11/14/2024	328	0.0%	134,373	9/30/2024
2024 Q2	8/15/2024	323	0.0%	125,828	6/30/2024
2024 Q1	5/7/2024	1,006	0.0%	344,438	3/31/2024
2023 Q4	2/14/2024	106	0.0%	45,916	12/31/2023
2023 Q3	11/14/2023	34	0.0%	13,068	9/30/2023
2023 Q2	8/11/2023	313	0.0%	87,503	6/30/2023
2023 Q1	5/16/2023	31	0.0%	14,189	3/31/2023
2022 Q4	2/14/2023	2,233	0.0%	185,606	12/31/2022
2022 Q3	11/14/2022	1,110	0.0%	171,337	9/30/2022
2022 Q2	8/15/2022	488	0.0%	106,638	6/30/2022
2022 Q1	5/16/2022	675	0.0%	77,985	3/31/2022
2021 Q4	2/14/2022	1,662	0.0%	116,408	12/31/2021
2021 Q3	11/15/2021	361	0.0%	16,432	9/30/2021
2021 Q2	8/11/2021	161	0.0%	12,002	6/30/2021
2021 Q1	5/17/2021	694	0.0%	68,305	3/31/2021
2019 Q4	2/14/2020	70	0.0%	13,628	12/31/2019
2014 Q1	5/14/2014	282	0.0%	24,281	3/31/2014